Palisade Bio, Inc.
PALI
$0.7556
-$0.0207-2.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -14.44M | -14.07M | -14.17M | -13.49M | -12.30M |
| Total Depreciation and Amortization | 3.00K | 3.00K | 3.00K | 4.00K | 4.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 851.00K | 832.00K | 1.26M | 838.00K | 763.00K |
| Change in Net Operating Assets | 1.39M | 672.00K | 823.00K | 1.86M | 400.00K |
| Cash from Operations | -12.19M | -12.56M | -12.09M | -10.79M | -11.13M |
| Capital Expenditure | -- | 0.00 | 0.00 | -4.00K | -4.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 0.00 | 0.00 | -4.00K | -4.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -426.00K | -371.00K | -411.00K | -461.00K | -391.00K |
| Issuance of Common Stock | 10.95M | 6.53M | 8.27M | 9.76M | 12.19M |
| Repurchase of Common Stock | -25.00K | -25.00K | -25.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -919.00K | -849.00K | -796.00K | -525.00K | -617.00K |
| Cash from Financing | 9.58M | 5.29M | 7.04M | 8.77M | 11.19M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.61M | -7.27M | -5.05M | -2.02M | 49.00K |